Liothyronine
Indication
Liothyronine therapy commenced in the private sector
Black
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
Patients that are commenced on liothyronine in the private sector should receive ongoing prescriptions and associated monitoring from the private sector. If the patient commences or resumes NHS care following treatment for hypothyroidism by a private specialist the patient should be evaluated against NHS criteria and treatment commenced in line with NHS recommendations only if they fulfill the local NHS initiation criteria.
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: